Marvin L. White - 29 Jan 2022 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: President and CEO, Director
Signature: /s/ Carl A. Valenstein, attorney-in-fact
Issuer symbol: APVO
Transactions as of: 29 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Feb 2022, 17:01:53 UTC
Previous filing: 24 May 2021
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+4,792	+23%		25,764	29 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	+4,792	+100%	$0.000000	9,583	29 Jan 2022	Common Stock	4,792		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On January 29, 2021, the reporting person was granted 14,375 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022.